Abstract Orchestrated upregulation of cell surface presentation of ganglioside GM1 and homodimeric galectin-1 is the molecular basis for growth regulation of human neuroblastoma (SK-N-MC) cells. Further study led to the discovery of competitive inhibition by galectin-3, prompting us to test tandem-repeat-type galectin-4 (two different lectin domains connected by a 42-amino-acid linker). This lectin bound to cells at comparably high affinity without involvement of the ganglioside, as disclosed by assays in the presence of cholera toxin B-subunit or galectin-1 and blocking glucosylceramide synthesis. Notably, when tested separately, binding of both lectin domains showed partial sensitivity to the bacterial agglutinin. Despite its ability for cross-linking surface association of galectin-4 did not affect proliferation, in contrast to homodimeric galectins. The truncation of linker length from 42 to 16 amino acids altered binding properties to let partial sensitivity to the bacterial lectin emerge. Crosscompetition between parental and engineered proteins did not exceed 40%. No effect on cell growth was detected. This study reveals complete functional divergence between galectins differing in the spatial mode of lectin-site presentation and dependence of reactivity to distinct counter-receptor(s) on linker length. Due to the documented presence of galectin-4 in the nervous system and its affinity for sulfatide these in vitro results indicate the potential for a distinct functionality profile of this lectin in vivo, giving further research direction.
Introduction
The structural diversity of biomolecules underlies their versatile ability to engage in specific intermolecular recognition. Historically, the study of the interplay between proteins has dominated analysis of cell surface processes. The growing awareness of the unsurpassed capacity of carbohydrates for variability on the level of oligomers yet gives reason for serious rivalry. In fact, glycan chains are second to no other class of biomolecules in capacity to store bioinformation, the basis of the concept of the sugar code [1] . Physiologically, it thus is not surprising to find sugar chains, as part of glycoconjugates, spatially readily accessible on cell surfaces and in the extracellular matrix. Equally in line with assumed functionality, carbohydratespecific tools (antibodies, lectins) have revealed intricate changes in the profile of glycan structures (glycome) associated with alterations of cell parameters such as status of differentiation or malignancy [2] [3] [4] [5] . Matching presence of endogenous receptors will then establish recognition systems, proven to be involved in diverse aspects of cell sociology, e.g. cell adhesion or growth regulation [6] . This perspective explains the interest given to monitoring glycans and presence of endogenous lectins in the nervous system [7] .
Using carrier-immobilized glycans as tools, such endogenous lectins have been detected in the mammalian peripheral and central nervous system [8] [9] [10] [11] . Abundance of histochemical staining with b-galactosides used as sensors, purification of a cognate lectin, its immunolocalization and reactivity with neural glycoconjugates has then quickly provided experimental proof-of-principle for the potential of this mode of information transfer in neurochemical research [10, [12] [13] [14] [15] [16] . The respective protein (a homodimer of about 29 kDa) has become the proto-type of the lectin family of galectins. They are potent effectors, which share b-sandwich folding and a sequence signature with a central tryptophan as essential contact site for the galactoside core of carbohydrate ligands [17, 18] . The mentioned protein, termed galectin-1 (Gal-1), for example regulates proliferation of adult neural stem cells [19] [20] [21] , plays a role in sensory axon pathfinding [22, 23] and effects axonal regeneration via carbohydrate-dependent/independent mechanisms [24, 25] . While it is certainly of interest to continue to explore its activity profile, the detection of expression of other galectins in neural cells [26] [27] [28] [29] raises the question on the possibility for functional overlap or antagonism in the emerging network. In order to address this issue work with suitable model systems with welldefined responses to galectin presence is required.
Toward this end, our previous studies centered on the human SK-N-MC neuroblastoma cell line, explicitly the growth control and differentiation initiated by the activity increase of cell surface ganglioside sialidase [30] . This work revealed the prominent role of Gal-1 by binding to ganglioside GM1, the product of the enzymatic desialylation, as functional counter-receptor [31] . The upregulation in cell surface presentation of both the galectin and the ganglioside appears perfectly orchestrated. Of note, with respect to target selection, neural cells are unique among human cell types ''in possessing gangliosides (rather than glycoproteins) as the predominant sialoglycoconjugates'' [32] , and Gal-1, along with the similarly homodimeric (cross-linking) galectins-2 and -7, elicits growth inhibition by targeting this ganglioside presented in microdomains [33] [34] [35] [36] . In contrast to the proto-type proteins, the chimeratype galectin-3 (Gal-3), a monomer in solution with a collagenase-sensitive stalk, is not active as growth modulator [32] . On the level of the cell surface, it acts as a competitive inhibitor for the proto-type proteins, establishing a case of functional divergence [33, 34] .
This discovery leads to the question how a tandemrepeat-type galectin (protein with two different carbohydrate recognition domains covalently connected by a linker peptide) will perform in this model. Galectin-4 (Gal-4) is such a protein. It is pivotal in apical routing in enterocytelike cells by affinity to sulfatide and the cargo for transport, i.e. distinct glycoproteins rich in N-glycans with N-acetyllactosamine termini [37] [38] [39] [40] . Carbohydrate-specificity assays and cytochemical reactivity to a glycoprotein matrix had disclosed similarities of Gal-4 to galectins-1 and -3 as was binding to ganglioside GM1 in microtiter plate wells [41] [42] [43] . On this basis, it was thus tempting to test for cell surface binding and an effect on cell growth with this protein in the neuroblastoma system. Since the presence of the linker peptide between the two different domains is a hallmark of tandem-repeat-type galectins, we also examined an engineered variant with reduced linker length under identical conditions.
Materials and Methods

Galectins
Human galectin-4 (Gal-4), its two lectin parts referred to as N-and C-terminal domains (Gal-4N/C) and the engineered variant with a 26mer truncation in the 42-amino-acid-long linker (Gal-4 V), which maintains the phylogenetically highly conserved 3/13mer-peptide stretches at each side [44] , were obtained by recombinant production, chromatographically purified, checked by one-and two-dimensional gel electrophoresis for purity and controlled for activity by solid-phase binding assays and calorimetry, strictly ensuring activity of each domain [45] [46] [47] . Human Gal-1 was purified as described previously [36] .
Cell Culture
Neuroblastoma cells (strain SK-N-MC) were routinely cultured in Eagle's minimal essential medium containing 10% fetal calf serum (PAA Laboratories, Cölbe, Germany) and antibiotics. To reduce cellular content of ganglioside GM1 N-butyldeoxynojirimycin (NB-DNJ; Sigma-Aldrich, Taufkirchen, Germany), a specific inhibitor of biosynthesis of glucosylceramide, was applied. This reagent was added to the culture medium to reach a final concentration of 50 lM and applied for 5 days. Thereafter, the cells were subcultured into 96-well plates and grown for further 5 days in the presence of NB-DNJ prior to conducting the binding assays. For cholesterol depletion, the cells were grown to 90% confluency, then treated with 3 lg/ml filipin III (Sigma-Aldrich) for one h at 37°C in serum-free medium, before binding assays were performed [36] .
Binding and Growth Assays
Galectins were radioiodinated using carrier-free Na 125 I (Hartmann Analytic, Braunschweig, Germany) and Iodobeads (Pierce, Bonn, Germany) in the presence of 100 mM lactose to protect the lectin site(s) in 50 mM sodium phosphate, pH 7.0, followed by separation from free iodine and lactose by gel filtration (PD-10 column; Amersham Biosciences). Specific radioactivities were 215 KBq/lg for Gal-4, 195 KBq for Gal-4 V, 245 KBq/lg for Gal-4N, 224 KBq/lg for Gal-4C and 259KBq/lg for Gal-1. Cells seeded in 96-well tissue plates were routinely grown to confluency within a period of 5 days (approximately 10 5 cells/well) and were further incubated for 16 h in serumfree medium. To avoid non-specific binding of proteins to cells Eagle's minimal essential medium containing 25 mM HEPES (pH 7.4) was supplemented with 0.01% (w/v) carbohydrate-free bovine serum albumin. The incubation period was 2 h at 37°C. It was followed by three thorough washes with 200 ll 20 mM phosphate-buffered saline (pH 7.4) to remove unbound radioactive probe and solubilization of cells in 100 ll 0.2 M NaOH. Competitive assays were performed by adding increasing concentrations of galectin or 25 lg cholera toxin B-subunit (Ctx-B; Sigma, Munich, Germany) one h prior to the radioiodinated protein as described [33, 34] . Radioactivity was routinely quantified in a liquid scintillation counter (TRI-CARB 2900TR; PerkinElmer, Rodgau, Germany). To determine the effect of galectins and the B-subunit of the bacterial toxin on cell growth aliquots of a cell suspension 16 h after seeding were used for an experimental period of 48 h under routine culture conditions, extent of cell proliferation being determined with a commercial kit (CellTiter 96; Promega, Mannheim, Germany) as described [33, 34] .
Results
Quantitation of Cell Surface Binding of Gal-4 and its Domains
To enable comparison to data sets with the already studied proto-and chimera-type family members, Gal-4 was also radioiodinated under activity-preserving conditions. Its cell binding was mostly inhibitable by a mixture of lactose and a glycoprotein with pan-galectin reactivity, i.e. asialofetuin, and saturable (Figs. 1, 2) . Calculation of the dissociation constant resulted in a value of around 130 nM, markedly smaller than those for the other human galectins tested so far (Table 1 ). In comparison, it appears to be rather close to the K D measured for Ctx-B at 50 nM [31] . Also, the calculated number of bound lectin molecules per cell at saturation differed considerably from the respective data for the other proteins (Table 1) . It was by far the smallest, about a fifth compared to galectins-1, -2, -3 or -7, less than a tenth relative to Ctx-B. These quantitative data imply disparities in the selection of cell surface ligands. Since ganglioside GM1 is the major counter-receptor for human galectins-1, -2, -3 and -7 in these cells, we could use Ctx-B, a specific receptor for this ganglioside without affinity to glycoproteins, to test the effect of its presence, which will block access to this glycolipid's pentasaccharide. Figure 2 shows that the addition of the reagent, in this case, did not reduce the extent of interaction of cells with the galectin. Obviously, this tandem-repeat-type galectin maintains cell surface reactivity in the presence of Ctx-B. In order to confirm an assumed importance of the combined display of two different domains in one protein we next studied binding of each module separately, i.e. Gal-4N/C domains.
In each case, the obtained binding curve reflected a more complex profile than for the parental form, obstructing a K D -calculation. Extent of binding was higher for Gal-4C (Fig. 3a) than for Gal-4N (Fig. 3b) , an indication for differences in ligand selection. When Ctx-B was present, partial inhibition was seen, stronger for Gal-4N than for Gal-4C (Fig. 3) . In contrast, as shown above, the These results prompted us to study next, whether (1) clustered ligand presentation in microdomains is required to yield the measured affinity for Gal-4, (2) a reduction in ganglioside GM1 presence will have a bearing on the B maxvalue and (3) the potent effector Gal-1 will compete for cell binding with Gal-4 and vice versa.
Modulation of Gal-4 Binding by Cell Surface Alterations and Gal-1 Presence
The topology of presentation of glycoconjugates in microdomains was impaired by the macrolide filipin III, under conditions not altering the overall ganglioside content [36] . This parameter change reduced the affinity nearly twofold with no effect on extent of binding at saturation (Fig. 4) . Integrity of microdomains is not essential but contributes to the affinity. Using NB-DNJ to drastically reduce glucosylceramide synthesis and thus ganglioside abundance, as confirmed by measuring amount of lipidbound neuraminic acid, a rather similar effect was seen (Fig. 4) . The number of reactive sites remained constant, indicating that a variation in ganglioside GM1 presentation has no influence, in accord with the lack of effect of Ctx-B (Fig. 2) . As such, the data pinpoint a drastic difference to the previously determined properties of galectins-1 and -3 [36] .
To further substantiate this inter-galectin divergence we next performed competitive-inhibition studies, first using label-free Gal-1 to interfere with binding of Gal-4. Up to a 50-fold excess to ensure effective competition despite the observed affinity difference, a reduction of only around 20% was reached (Fig. 5a ). The effect of label-free Gal-4 on binding of Gal-1 was even less, excluding any influence of affinity differences (Fig. 5b) . Thus, Gal-4 did not share binding sites with Gal-1 to a major extent. This result suggests that the proto-and tandem-repeat-type galectins are different in capacity for growth regulation.
Effects of Gal-4/Ctx-B on Cell Growth
This issue is resolved by cell assays in the presence of galectins. In the first step establishing the positive control, we confirmed the strong inhibition of cell growth by Gal-1 (Fig. 6) . In stark contrast, Gal-4 binding to the cell surface [31] b From [34] c From [35] did not cause any effect on proliferation (Fig. 6) . Also, the two domains tested under identical conditions, separately or as mixture, did not influence cell growth (Table 1) . Of note, Ctx-B was also devoid of inhibitory capacity (Fig. 6) . Although Gal-4 with its two domains is a cross-linking device like Gal-1, it is functionally different, due to disparate counter-receptor selection and/or the presence of the linker. In order to probe into the relevance of linker properties, a truncated variant (from the natural length of 42 amino acids to 16 amino acids maintaining phylogenetically highly conserved stretches at each side) was engineered, termed Gal-4 V, and respective binding/cell growth studies performed.
Properties of Cell Surface Binding of Gal-4 V
The extent of binding of this variant was clearly higher than for the wild-type protein (Figs. 2, 7) . When testing the effect of Ctx-B, partial sensitivity was detected, as noted before for the domains (Figs. 3, 7) . Beyond this observation, the obtained binding data in the presence of the reagent allowed K D /B max -calculations (Fig. 7) . Of note, the Ctx-B-sensitive part reached a B max -value which is similar to those of the other galectins interacting with cell surface ganglioside GM1, albeit at a markedly enhanced affinity ( Table 1) . As to the Ctx-B-insensitive binding, the respective K D -value was well below 100 nM. These data indicate that the linker length has a bearing on binding properties, both in terms of affinity and ligand selection. As further means to trace impact of linker-length truncation on binding properties and to solidify the indication for a difference competition assays with Gal-4 and also with Gal-1 were performed. Although the two lectin domains were not altered, the level of competitive inhibition of Gal-4 binding by Gal-4 V was only moderate, reflecting the emergence of the Ctx-B-sensitive part in the overall binding of the truncated version (Figs. 5a, 7) . Fittingly, Gal-4 V could interfere with Gal-1 binding to a higher extent than Gal-4, the difference yet being rather small (Fig. 5b ). An effect of Gal-4 V on cell growth was not detectable when tested up to 125 lg/ml (Table 1) .
Discussion
Since the discovery of neuritogenic/neuronotrophic properties, diverse routes gangliosides take to exert their functionality have been delineated, e.g. by modulating the activity of membrane-associated enzymes, cation channels or integrins [32, [48] [49] [50] [51] [52] . Of note, gangliosides are an excellent example for the dynamics of changes in sugarencoded information. The presence of glycohydrolases on the cell surface affords the opportunity for swift changes in the ganglioside profile [53] , and such an enzymatic remodelling from higher sialylated versions to GM1's pentasaccharide has been shown to be decoded by an endogenous lectin (i.e. Gal-1) in human neuroblastoma (SK-N-MC) cells [31] . This cell line is characterized by a ganglioside profile rich in GM3, GM1, GD1a and GM1 (given in order of abundance [54] , with heterogeneity in this feature among neuroblastoma lines concerning shifts to GD2, GM2 and/or GT1b being documented [55] . The noted kind of intimate orchestration of cell surface presentation of a ganglioside (i.e. GM1) along with its cognate effector (i.e. Gal-1) has also been delineated recently in T cell communication, expanding its range beyond neuronal cells [56, 57] . Thus, ganglioside GM1 is a counter-receptor for a galectin, and the neuroblastoma system is suitable to answer questions on the degree of functional divergence in the galectin network. This study initiates respective work with tandem-repeat-type galectins and teaches two salient lessons on Gal-4 in this respect. This tandem-repeat-type galectin did not share the property to bind to ganglioside GM1 on the neuroblastoma cell surface with proto-and chimera-type proteins. Presence of Ctx-B failed to affect extent of cell binding. In accord with this result, the B max -value was not altered by the pronounced reduction in ganglioside content for NB-DNJ-treated cells. Looking at galectins-1 and -3, their binding was effectively lowered by this type of inhibition of glucosylceramide synthesis [36] . The apparently different ligand selection, also seen by a lack of inhibitory activity of Gal-1 in experiments with co-incubation, was reflected in the growth assays. Here, Gal-4 showed no activity. Thus, Gal-4 is neither a growth modulator as homodimeric proto-type galectins nor a competitive inhibitor of these proteins as the chimera-type Gal-3. Obviously, these closely related proteins exhibit wide functional divergence, which can also be relevant for intracellular processes due to the presence of galectins and gangliosides in nuclei [58] [59] [60] . The cases of Gal-3 [33] and Ctx-B [this report], both without effect on cell growth although having reactivity to ganglioside GM1 in common with proto-type galectins, disclosed that a certain topological constellation of lectin-ligand complexes, accomplished by cross-linking, is required for triggering growth inhibition. Neither Ctx-B nor Gal-3 can generate the postbinding effects as proto-type Gal-1 (or Gal-2/-7) does. These results imply that ligand selection together with spatial aspects, determined by the way lectin sites are displayed, underlie the functional specificity of each lectin. If this reasoning is correct, then the length of the linker in Gal-4 should matter.
The second major insight gained by this study concerns the significance of the nature of the linker peptide. Naturally, only one length is found for human Gal-4 [44] . Size reduction to let the variant protein more resemble prototype proteins was tested in this study. The truncation caused changes in ligand selection relative to the parental Gal-4, bringing to light that its structural design hereby means more than enabling a covalent connection of two domains. In detail, occurrence of sensitivity to Ctx-B in contrast to parental Gal-4 (Figs. 2, 7 ) and only partial inhibition in co-incubation for Gal-4/Gal-4 V pairs (Fig. 5 ) signified a major impact by the deletion of 26 amino acids. Hydrodynamic measurements (i.e. determination of translational diffusion constants) of both proteins had earlier come up with a counterintuitive decrease of this parameter for Gal-4 V and also the acquisition of its sensitivity to presence of lactose [61] . Apparently, the natural linker length lets the two lectin sites adopt a distinct topological mode of presentation, which is lost upon truncation. That binding of the engineered Gal-4 variant was sensitive to Ctx-B, as likewise exhibited by the separate domains, supports this reasoning.
The structural design of a tandem-repeat-type galectin therefore not only facilitates to combine two different domains (in contrast to homodimeric proteins). Moreover, they are brought into a special type of spatial presentation, its elucidation posing an attractive challenge to biophysical chemistry. By extrapolating this emerging concept, it can be assumed that natural variations of this parameter, as present in galectin-8 [44, 62] , may work on the lectin sites like molecular switches. This hypothesis gives further experiments with the neuroblastoma model system a clear direction. Indeed, in the framework of a network for galectins as it is shaping up, with cases known with functional competition [33, 63] and monitoring of tissue presence (galectin fingerprinting) revealing complex patterns [64] [65] [66] [67] [68] [69] [70] , delineation of definitive structure-activity relationships in well-defined, physiologically relevant cell systems will help track down the individual functionality profile of each family member. Also, Gal-4's capacity to interact with sulfatide [38] , a major constituent of myelin (so far not documented to be present in human neuroblastoma cells, conversely even deliberately excluded in the case of CRL-2268 cells [71] ) , and the lectin's expression by rat oligodendrocytes [72] warrant further neurochemical studies.
